The impact of the COVID-19 pandemic on patients awaiting spinal cord stimulation surgery in the United Kingdom: a multi-centre patient survey

Author:

Baranidharan Ganesan12,Bretherton Beatrice13ORCID,Eldabe Sam4ORCID,Mehta Vivek5,Thomson Simon6,Sharma Manohar Lal7,Vajramani Girish8,Bojanic Stana9,Gulve Ashish4,FitzGerald James910,Hall Samuel8,Firth Julie1

Affiliation:

1. Leeds Pain and Neuromodulation Centre, Leeds Teaching Hospitals NHS Trust, Leeds, UK

2. School of Medicine, Faculty of Medicine and Health, University of Leeds, Leeds, UK

3. School of Biomedical Sciences, Faculty of Biological Sciences, University of Leeds, Leeds, UK

4. Department of Pain Medicine, The James Cook University Hospital, Middlesbrough, UK

5. Pain and Anaesthesia Research Centre, St Bartholomew’s Hospital, London, UK

6. Department of Anaesthesiology, Basildon and Thurrock University Hospitals, Basildon, UK

7. Department of Pain Medicine, The Walton Centre NHS Foundation Trust, Liverpool, UK

8. Wessex Neurological Centre, University Hospital Southampton, Southampton, UK

9. Department of Neurosurgery, The John Radcliffe Hospital, Oxford, UK

10. Nuffield Department of Surgical Sciences, University of Oxford, Oxford, UK

Abstract

Introduction: Spinal cord stimulation (SCS) is a recommended treatment for chronic refractory neuropathic pain. During the COVID-19 pandemic, elective procedures have been postponed indefinitely both to provide capacity to deal with the emergency caseload and to avoid exposure of elective patients to COVID-19. This survey aimed to explore the effect of the pandemic on chronic pain in this group and the views of patients towards undergoing SCS treatment when routine services should resume. Methods: This was a prospective, multi-centre telephone patient survey that analysed data from 330 patients with chronic pain who were on an SCS waiting list. Questions focussed on severity of pain, effect on mental health, medication consumption and reliance on support networks during the COVID-19 pandemic. Views towards undergoing SCS therapy were also ascertained. Counts and percentages were generated, and chi-square tests of independence explored the impact of COVID-19 risk (very high, high, low) on survey responses. Results: Pain, mental health and patient’s ability to self-manage pain deteriorated in around 47%, 50% and 38% of patients, respectively. Some patients reported increases in pain medication consumption (37%) and reliance on support network (41%). Patients showed a willingness to attend for COVID-19 testing (92%), self-isolate prior to SCS (94%) and undergo the procedure as soon as possible (76%). Conclusion: Our findings suggest that even during the COVID-19 pandemic, there remains a strong clinical need for patients with chronic pain identified as likely SCS responders to be treated quickly. The current prioritisation of new SCS at category 4 (delayed more than 3 months) is challenged judging by this national survey. These patients are awaiting SCS surgery to relieve severe intractable neuropathic pain. A priority at category 3 (delayed up to 3 months) or in some selected cases, at category 2 are the appropriate priority categories.

Publisher

SAGE Publications

Subject

Anesthesiology and Pain Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3